Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07633847 · ClinicalTrials.gov registry record
A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.
A clinical trial, sponsored by AnX Robotica.
- Not yet
- Registry status
- 92
- Enrollment target
NCT07633847: Clinical Trial study, sponsored by AnX Robotica.
NCT07633847 is a clinical trial that has not yet begun recruiting, run by AnX Robotica. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07633847 has not yet begun recruiting, sponsored by AnX Robotica.
- NOT YET RECRUITING
- Registry status
- 92 participants
- Enrollment target
Study Summary
NaviCam ProScan is an artificial intelligent (AI) assisted reading tool designed to aid small bowel capsule endoscopy reviewers in decreasing the time to review capsule endoscopy images for adult patients in whom the capsule endoscopy images were obtained for suspected small bowel bleeding.
Primary Outcome
Subject-level sensitivity will be evaluated for superiority of ProScan assistance versus unassisted assessments in the identification of patients with one or more true findings.
Interventions
- DEVICE Video capsule endoscopy
- OTHER Phase II = Data analysis by Independent Readers
- OTHER Phase III = Data Analysis by Expert Readers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2028-09-15 |
What is known before NCT07633847 opens enrollment
NCT07633847 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Video capsule endoscopy is the first listed.
NCT07633847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07633847 about?
NCT07633847 is a clinical study titled "A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.". NaviCam ProScan is an artificial intelligent (AI) assisted reading tool designed to aid small bowel capsule endoscopy reviewers in decreasing the time to review capsule endoscopy images for adult patients in whom the capsule endoscopy images were obtained for suspected small bowel bleeding.
What is the current status of trial NCT07633847?
This trial is currently not yet recruiting. The enrollment target is 92 participants. The study started on 2026-06-15. Estimated completion is 2028-09-15.
What interventions are being tested in trial NCT07633847?
The interventions under investigation include: Video capsule endoscopy (DEVICE), Phase II = Data analysis by Independent Readers (OTHER), Phase III = Data Analysis by Expert Readers (OTHER).
Who is sponsoring clinical trial NCT07633847?
This trial is sponsored by AnX Robotica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI